ArticleHaematologica2021

Efficacy of minimal residual disease driven immune-intervention after allogeneic hematopoietic stem cell transplantation for high-risk chronic lymphocytic leukemia: results of a prospective multicenter trial.

Olivier Tournilhac et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.